Works by Yeung-Chul Mun


Results: 81
    1
    2

    Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Won Seog Kim;
    • Hyeon Seok Eom;
    • Deok-Hwan Yang;
    • Sung Hwa Bae;
    • Hyo Jung Kim;
    • Jae Hoon Lee;
    • Suk-Joong Oh;
    • Sung-Soo Yoon;
    • Jae-Yong Kwak;
    • Chul Won Choi;
    • Min Kyoung Kim;
    • Sung Young Oh;
    • Hye Jin Kang;
    • Seung Hyun Nam;
    • Hyeok Shim;
    • Joon Seong Park;
    • Yeung-Chul Mun;
    • Cheolwon Suh
    Publication type:
    Article
    3

    Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 304, doi. 10.4143/crt.2022.004
    By:
    • Kyoung Ha Kim;
    • Jae Hoon Lee;
    • Mark Lee;
    • Hoon-Gu Kim;
    • Young Rok Do;
    • Yong Park;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Seog Kim;
    • Seong Kyu Park;
    • Jee Hyun Kong;
    • Moo-Rim Park;
    • Deok-Hwan Yang;
    • Jae-Yong Kwak;
    • Hye Jin Kang;
    • Yeung-Chul Mun;
    • Jong-Ho Won
    Publication type:
    Article
    4
    5

    Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 2, p. 590, doi. 10.4143/crt.2017.172
    By:
    • Jung Hye Choi;
    • Tae Min Kim;
    • Hyo Jung Kim;
    • Sung Ae Koh;
    • Yeung-Chul Mun;
    • Hye Jin Kang;
    • Yun Hwa Jung;
    • Hyeok Shim;
    • So Young Chong;
    • Der-Sheng Sun;
    • Soonil Lee;
    • Byeong Bae Park;
    • Jung Hye Kwon;
    • Seung-Hyun Nam;
    • Jun Ho Yi;
    • Young Jin Yuh;
    • Jong-Youl Jin;
    • Jae Joon Han;
    • Seok-Hyun Kim
    Publication type:
    Article
    6
    7
    8
    9
    10

    Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CT.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00577-2
    By:
    • Cho, Hee Jeong;
    • Jung, Sung-Hoon;
    • Jo, Jae-Cheol;
    • Lee, Yoo Jin;
    • Yoon, Sang Eun;
    • Park, Sung-Soo;
    • Kim, Do Young;
    • Shin, Ho-Jin;
    • Mun, Yeung-Chul;
    • Yi, Jun Ho;
    • Kim, Hyo Jung;
    • Kim, Da Jung;
    • Lee, Ho Sup;
    • Bae, Sung Hwa;
    • Hong, Chae Moon;
    • Jeong, Shin Young;
    • Min, Jung-Joon;
    • Sohn, Sang Kyun;
    • Min, Chang-Ki;
    • Kim, Kihyun
    Publication type:
    Article
    11
    12
    13

    Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 11, p. 2714, doi. 10.1080/10428194.2020.1783448
    By:
    • Song, Ga-Young;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Jin Seok;
    • Min, Chang-Ki;
    • Kim, Kihyun;
    • Choi, Yunsuk;
    • Eom, Hyeon-Seok;
    • Joo, Young Don;
    • Kim, Sung-Hyun;
    • Kwak, Jae-Yong;
    • Kang, Hye Jin;
    • Lee, Jae Hoon;
    • Lee, Ho Sup;
    • Mun, Yeung-Chul;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Seong Kyu;
    • Park, Yong;
    • Shin, Ho-Jin
    Publication type:
    Article
    14

    Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 2, p. 341, doi. 10.3109/10428194.2015.1049166
    By:
    • Park, Joon Seong;
    • Lee, Sung-Eun;
    • Jeong, Seong Hyun;
    • Jang, Eun-Jung;
    • Choi, Mi-Yeon;
    • Kim, Hyeoung-Joon;
    • Kim, Yeo-Kyeoung;
    • Kim, Sung-Hyun;
    • Zang, Dae Young;
    • Oh, Sukjoong;
    • Koo, Dong Hoe;
    • Kim, Hawk;
    • Do, Young Rok;
    • Kwak, Jae-Yong;
    • Kim, Jeong-A;
    • Kim, Dae-Young;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Chang, Myung Hee;
    • Park, Jinny
    Publication type:
    Article
    15

    The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

    Published in:
    Acta Haematologica, 2018, v. 140, n. 3, p. 146, doi. 10.1159/000490488
    By:
    • Lee, Gyeong-Won;
    • Park, Sung Woo;
    • Go, Se-Il;
    • Kim, Hoon-Gu;
    • Kim, Min Kyoung;
    • Min, Chang-Ki;
    • Kwak, Jae-Yong;
    • Bae, Sang-Byung;
    • Yoon, Sung-Soo;
    • Lee, Je-Jung;
    • Kim, Ki Hwan;
    • Nam, Seung-Hyun;
    • Mun, Yeung-Chul;
    • Kim, Hyo Jung;
    • Bae, Sung Hwa;
    • Shin, Ho-Jin;
    • Lee, Jung-Hee;
    • Park, Joon Seong;
    • Jeong, Seong Hyun;
    • Lee, Mark Hong
    Publication type:
    Article
    16

    Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.

    Published in:
    Acta Haematologica, 2015, v. 134, n. 1, p. 40, doi. 10.1159/000368711
    By:
    • ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Min, Yoo Hong;
    • Cheong, June-Won;
    • Jang, Jun Ho;
    • Jung, Chul Won;
    • Kim, In Ho;
    • Yoon, Hwi-Joong;
    • Lee, Hong Ghi;
    • Sohn, Sang Kyun;
    • Moon, Joon Ho;
    • Kim, Hawk;
    • Kim, Yoo-Jin;
    • Won, Jong-Ho;
    • Chung, Joo-Seop;
    • Mun, Yeung Chul;
    • Lee, Je-Hwan;
    • Kim, Hyeoung-Joon
    Publication type:
    Article
    17
    18
    19
    20

    Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.

    Published in:
    Acta Haematologica, 2009, v. 122, n. 4, p. 200, doi. 10.1159/000253027
    By:
    • Kim, Seok Jin;
    • Kim, Kihyun;
    • Kim, Byung Soo;
    • Jo, Deog-Yeon;
    • Kang, Hye Jin;
    • Kim, Jin Seok;
    • Mun, Yeung-Chul;
    • Kim, Chul Soo;
    • Sohn, Sang Kyun;
    • Eom, Hyeon-Seok;
    • Kwak, Jae-Yong;
    • Shim, Hyeok;
    • Yoon, Hwi-Joong;
    • Jin, Jong-Youl;
    • Min, Chang-Ki;
    • Shin, Hyunchoon;
    • Won, Jong-Ho;
    • Lee, Je-Jung;
    • Kwon, Jung Hye;
    • Joo, Young-Don
    Publication type:
    Article
    21
    22
    23
    24

    Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 4, p. 413, doi. 10.1002/ajh.25726
    By:
    • Ho Sup Lee;
    • Kihyun Kim;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Inho Kim;
    • Jin Seok Kim;
    • Hyeon-Seok Eom;
    • Dok Hyun Yoon;
    • Cheolwon Suh;
    • Ho-Jin Shin;
    • Yeung-Chul Mun;
    • Min Kyoung Kim;
    • Sung-Nam Lim;
    • Chul Won Choi;
    • Hye Jin Kang;
    • Sung-Soo Yoon;
    • Chang-Ki Min
    Publication type:
    Article
    25

    Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
    By:
    • Cho, Hyungwoo;
    • Yoon, Dok Hyun;
    • Lee, Jung Bok;
    • Kim, Sung-Yong;
    • Moon, Joon Ho;
    • Do, Young Rok;
    • Lee, Jae Hoon;
    • Park, Yong;
    • Lee, Ho Sup;
    • Eom, Hyeon Seok;
    • Shin, Ho-Jin;
    • Min, Chang-Ki;
    • Kim, Jin Seok;
    • Jo, Jae-Cheol;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Lee, Je-Jung;
    • Suh, Cheolwon;
    • Kim, Kihyun
    Publication type:
    Article
    26
    27

    A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 10, p. 961, doi. 10.1002/ajh.23281
    By:
    • Huh, Jungwon;
    • Kim, Hee-Je;
    • Jung, Chul Won;
    • Kim, Hee-Jin;
    • Kim, Sun-Hee;
    • Kim, Yeo-Kyeoung;
    • Kim, Hyeoung-Joon;
    • Shin, Myung Geun;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Kim, Sung Hyun;
    • Lee, Won Sik;
    • Won, Jong Ho;
    • Mun, Yeung Chul;
    • Kim, Hawk;
    • Park, Jinny;
    • Min, Woo Sung;
    • Kim, Dong Hwan (Dennis)
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S17, doi. 10.1016/j.clml.2017.09.045
    By:
    • Hee-Je Kim;
    • Hea-Lyun Yoo;
    • Won-Sik Lee;
    • Hyeong-Joon Kim;
    • Jee Hyun Kong;
    • Yunsuk Choi;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Sukjoong Oh;
    • Sung Hyun Kim;
    • Jeong-A. Kim;
    • Dae Young Zang;
    • Yeung-Chul Mun;
    • Young-Woong Won;
    • Sung-Eun Lee;
    • Dong-Wook Kim
    Publication type:
    Article
    34

    Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e70, doi. 10.1016/j.clml.2017.03.126
    By:
    • Kim, Min Kyoung;
    • Kim, Kihyun;
    • Yoon, Do Hyun;
    • Suh, Cheolwon;
    • Moon, Joon Ho;
    • Lee, Yoo Jin;
    • Lee, Jae Hoon;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Hyo Jung;
    • Bae, Sung Hwa;
    • Kim, Jin Seok;
    • Lee, Jeong-Ok;
    • Eom, Hyeon Seok;
    • Lee, Won-Sik;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Hyun, Myung Soo
    Publication type:
    Article
    35

    Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.133
    By:
    • Lee, Je-Jung;
    • Jung, Sung-Hoon;
    • Kim, Kihyun;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Min, Chang Ki;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Yong;
    • Lee, Ho Sup;
    • Kim, Sung-Hyun;
    • Shin, Ho-Jin;
    • Joo, Young Don;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Kwak, Jae-Young;
    • Kang, Hye Jin;
    • Choi, Yunsuk;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon
    Publication type:
    Article
    36

    The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e74, doi. 10.1016/j.clml.2017.03.135
    By:
    • Lee, Ho Sup;
    • Min, Chang Ki;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Lee, Jae Hoon;
    • Yoon, Do Hyun;
    • Kim, Inho;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Mun, Yeung-Chul;
    • Kim, Hyo Jung;
    • Park, Seong Kyu
    Publication type:
    Article
    37

    Clinical Features and Results of Bortezomib-Melphalan-Prednisone (VMP) as Initial Treatment in Elderly Multiple Myeloma Patients Received Lenalidomide with Dexamethasone (Len/Dex): Subgroup Analysis of Lenalidomide Registry from Korean Multiple Myeloma Working Party (KMM151)

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e129, doi. 10.1016/j.clml.2017.03.233
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Min, Chang Ki;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Lee, Jae Hoon;
    • Yoon, Do Hyun;
    • Kim, Inho;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Lim, Sung-Nam;
    • Cho, Su-Hee
    Publication type:
    Article
    38

    The outcomes of Korean Patients With Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e38, doi. 10.1016/j.clml.2017.03.067
    By:
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Yoon, Do Hyun;
    • Min, Chang Ki;
    • Sohn, Sang Kyun;
    • Choi, Chul Won;
    • Lee, Ho Sup;
    • Kim, Hyo Jung;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Yhim, Ho-Young;
    • Kim, Min Kyoung;
    • Jo, Jae-Cheol;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon;
    • Kim, Jin Seok
    Publication type:
    Article
    39
    40

    Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome.

    Published in:
    PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166245
    By:
    • Suh, Koung Jin;
    • Cheong, June-Won;
    • Kim, Inho;
    • Kim, Hyeoung-Joon;
    • Shin, Dong-Yeop;
    • Koh, Youngil;
    • Yoon, Sung-Soo;
    • Min, Yoo Hong;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Lee, Yun-Gyoo;
    • Lee, Jeong-Ok;
    • Bang, Soo-Mee;
    • Mun, Yeung-Chul;
    • Seong, Chu-Myoung;
    • Park, Yong;
    • Kim, Byung-Soo;
    • Hong, Junshik;
    • Park, Jinny;
    • Lee, Jae Hoon
    Publication type:
    Article
    41

    A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.

    Published in:
    2020
    By:
    • Yoon, Sang Eun;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Koh, Youngil;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Choi, Yoon Seok;
    • Yang, Deok Hwan;
    • Kim, Min Kyoung;
    • Lee, Gyeong-Won;
    • Suh, Cheolwon;
    • Ko, Young Hyeh;
    • Kim, Won Seog
    Publication type:
    journal article
    42

    The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).

    Published in:
    2020
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    journal article
    43
    44
    45
    46
    47

    Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1353, doi. 10.1007/s00277-014-2057-5
    By:
    • Oh, Sukjoong;
    • Koo, Dong;
    • Kwon, Min-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Min, Chang-Ki;
    • Yoon, Sung-Soo;
    • Shin, Ho-Jin;
    • Jo, Deog-Yeon;
    • Kwak, Jae-Yong;
    • Kim, Jin;
    • Sohn, Sang;
    • Joo, Young-Don;
    • Eom, Hyeon-Seok;
    • Kim, Sung-Hyun;
    • Kim, Yang;
    • Kim, ChulSoo;
    • Mun, Yeung-Chul;
    • Kim, Hawk;
    • Lee, Dong
    Publication type:
    Article
    48

    The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.

    Published in:
    2014
    By:
    • Kim, Jin Seok;
    • Cheong, June-Won;
    • Kim, Yeo-Kyeoung;
    • Park, Jinny;
    • Mun, Yeung-Chul;
    • Kang, Hye Jin;
    • Yi, Hyeon Gyu;
    • Lee, Je-Hwan;
    • Kim, Yang Soo;
    • Ryoo, Hun-Mo;
    • Kim, Sung-Hyun;
    • Kim, Ho Young;
    • Kim, Jin Young;
    • Lee, Dong-Gun;
    • Kim, Hoon-Gu;
    • Kim, Hawk;
    • Joo, Young-Don;
    • Min, Yoo Hong
    Publication type:
    Journal Article
    49
    50

    The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea

    Published in:
    Annals of Hematology, 2014, v. 93, n. 1, p. 33, doi. 10.1007/s00277-013-1826-x
    By:
    • Kim, Jin;
    • Cheong, June-Won;
    • Kim, Yeo-Kyeoung;
    • Park, Jinny;
    • Mun, Yeung-Chul;
    • Kang, Hye;
    • Yi, Hyeon;
    • Lee, Je-Hwan;
    • Kim, Yang;
    • Ryoo, Hun-Mo;
    • Kim, Sung-Hyun;
    • Kim, Ho;
    • Lee, Dong-Gun;
    • Kim, Hoon-Gu;
    • Kim, Hawk;
    • Joo, Young-Don;
    • Min, Yoo
    Publication type:
    Article